Seigo Nakamura M.D,
EDUCATION AND POST-GRADUATE TRAINING
1976 – 1982 Chiba University, School of Medicine
1999 EBM training at McMaster University, Ontario, Canada
1997 M.D.Anderson Cancer Center, Texas, U. S. A. from American Council for SLIMC foundation
BOARD CERTIFICATION
Board-certified in General Surgery in 1986
Board-certified in Breast Oncology in 1998
CURRENT ACADEMIC APPOINTMENTS
Professor and Chairman, Department of Surgery, Division of Breast Surgical Oncology,
Showa University School of Medicine
Director, Breast Center, Showa University Hospital
Visiting Assistant Professor, Showa University School of Pharmacy
Clinical Professor, St.Luke’s School of Nursing
Visiting Professor, The University of Tokushima
PREVIOUS PROFESSIONAL POSITIONS AND ACADEMIC APPOINTMENTS
1982 Resident (General Surgery) at St.Luke’s Internatioal Hospital, Tokyo
1987 Chief Resident at St.Luke’s International Hospital, Tokyo
1993 also, Director of Department Hospital Information System
1997 Assistant Chief of General Surgery at St.Luke’s International Hospital, Tokyo
2003 Chief of General Surgery at St.Luke’s International Hospital, Tokyo
2005 Director of Breast Surgical Oncology
2006 Director, Breast Center at St.Luke’s International Hospital, Tokyo
2010 Professor and Chairman, Department of Surgery, Division of Breast Surgical Oncology at Showa University School of Medicine Dicrector, Breast Center at Showa University Hospital
JOURNAL EDITOR/REVIEWER
International Journal of Clinical Oncology (Editorial Board)
The Journal of the Japanese Breast Cancer Society (Reviewer)
COMMITTEES
Board chairman in the Japanese Breast Cancer Society in 2014
Vice-Board chairman in the Japan Oncoplastic Breast Surgery Society in 2014
Auditor in the Japan Association of Breast Thyroid Societies in 2015
Clinical Guideline (Breast) Committee in Japan Society of Clinical Oncology in 2012
Executive board member in the Japan Oncoplastic Breast Surgery Society in 2013
A Council member of Breast Surgery International (BSI) 2013 Program
Board chairperson in NPO the Japanese HBOC Consortium in 2013
MEMBERSHIP AND FELLOWSHIP
American Society of Clinical Oncology (ASCO) in 2003
International Society of Surgery (ISS) in 2005
International Society of Cancer Risk Assessment & Management) (ISC-RAM) in 2004
A fellow of International College of Surgeons in 1997
OTHER ACTIIVITIES
President of the 23rd Annual Meeting of the Japanese Breast Cancer Society in 2015
HONORS AND AWARDS
2000 Best Presentation Award in Japanese Breast Cancer Society
1992 Best Presentation Award in Japanese Breast Imaging Society
RESEARCH GRANTS
1995 Development of 3-Dimensional MRI for Breast Conserving Surgery(Sato’s Memorial Cancer Fund)
1998-2001 Breast Imaging for Breast Conserving Surgery(Japanese Ministry of Health, Labour and Welfare)
2001-2003 Risk evaluation and Gene Counseling for Familial Breast cancer patients (St.Luke’s Life Science Institute)
2001-2003 Clinical Guideline for Breast Cancer(Japanese Ministry of Health, Labour and Welfare)
2002-2004 Clinical Guideline for Conserving Surgery
2003-2005 Clinical Guideline for Improvement of Prognosis for High Risk Recurrence Breast cancer (Japanese Ministry of Health, Labour and Welfare )
2003-2005 Clinical Guideline for Breast Conserving Surgery(Japanese Ministry of Health, Labour and Welfare)
2003-2004 Electronic Medical Record System (Japanese Ministry of Health, Labour and Welfare)
2004-2005 EBM Survey (Japanese Ministry of Health, Labour and Welfare)
2006-2008 Implementation of Global Standard and Evaluation on Breast Cancer (Japanese Ministry of Health, Labour and Welfare) Principal investigator
2006-2008 Standardization of Pathological Diagnosis on Resection Stump for Breast Conserving Surgery and Appropriate Observation after operation (Japanese Ministry of Health, Labour and Welfare)
2006-2008 Randomized Phase II Study of Pre-operative systemic Chemotherapy of Trastuzumab Chemotherapy for HER2 Over-expressing Breast Cancer(Japanese Ministry of Health, Labour and Welfare)
2007-2009 Multicenter Study on Safety of Sentinel Node Biopsy for Axillary Lymph Node Metastasis Negative Primary Breast Cancer.(Japanese Ministry of Health, Labour and Welfare)
2009 Study on Outcome Research for Improved Quality of Medical Care.
2009 Efficacy Pre-operative Systemic Chemotherapy of Carboplatin for HER2-negative Breast Cancer. (Japanese Ministry of Health, Labour and Welfare)
2010-2012 Standardization of Sentinel Node Biopsy for Neoadjuvant Breast Cancer. (Japanese Ministry of Health, Labour and Welfare) Principal investigator
2010-2011 Randomized Clinical Trial on Neo-adjuvant Study for DTX followed by FEC and weekly Nab-paclitaxel Followed by FEC for Primary Brest Cancer. (Japan Society of Clinical Oncology)
Principal investigator
2010-2011 Prevalence and Differentiation of Hereditary Breast and Ovarian Cancers in Japan. (The Japanese Breast Cancer Society)
Principal investigator.
2012-2013 Study on Effect for Diffusion of Clinical Guideline from the Point View of Cancer Registration. (Japanese Ministry of Health, Labour and Welfare)
|